- Home
- SNDX vs ECPG Comparison
SNDX vs ECPG Comparison
Compare SNDX & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- ECPG
- Stock Information
- Founded
- SNDX 2005
- ECPG 1998
- Country
- SNDX United States
- ECPG United States
- Employees
- SNDX N/A
- ECPG N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- ECPG Finance Companies
- Sector
- SNDX Health Care
- ECPG Finance
- Exchange
- SNDX Nasdaq
- ECPG Nasdaq
- Market Cap
- SNDX 1.1B
- ECPG 1.1B
- IPO Year
- SNDX 2016
- ECPG 1999
- Fundamental
- Price
- SNDX $14.41
- ECPG $50.21
- Analyst Decision
- SNDX Strong Buy
- ECPG Strong Buy
- Analyst Count
- SNDX 10
- ECPG 3
- Target Price
- SNDX $36.20
- ECPG $65.00
- AVG Volume (30 Days)
- SNDX 2.1M
- ECPG 133.9K
- Earning Date
- SNDX 02-25-2025
- ECPG 02-26-2025
- Dividend Yield
- SNDX N/A
- ECPG N/A
- EPS Growth
- SNDX N/A
- ECPG N/A
- EPS
- SNDX N/A
- ECPG N/A
- Revenue
- SNDX $16,000,000.00
- ECPG $1,328,129,000.00
- Revenue This Year
- SNDX N/A
- ECPG $18.76
- Revenue Next Year
- SNDX N/A
- ECPG $13.57
- P/E Ratio
- SNDX N/A
- ECPG N/A
- Revenue Growth
- SNDX N/A
- ECPG 12.62
- 52 Week Low
- SNDX $12.06
- ECPG $39.64
- 52 Week High
- SNDX $25.34
- ECPG $54.55
- Technical
- Relative Strength Index (RSI)
- SNDX 55.67
- ECPG 62.26
- Support Level
- SNDX $12.40
- ECPG $47.23
- Resistance Level
- SNDX $13.16
- ECPG $49.63
- Average True Range (ATR)
- SNDX 0.70
- ECPG 1.24
- MACD
- SNDX 0.24
- ECPG 0.36
- Stochastic Oscillator
- SNDX 90.73
- ECPG 100.00
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchase portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumer repay their obligations and work toward financial recovery. Encore has only a reportable segment being portfolio purchasing and recovery.